Skip to main content

Advertisement

Log in

Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

To determine predictive factors for neonatal thrombocytopenia in deliveries with immune thrombocytopenia (ITP), we conducted a retrospective study at a tertiary hospital between 1997 and 2013. During this period, 30 women with ITP delivered 44 children. Neonatal thrombocytopenia (<100 × 109/L) at birth was observed in seven neonates; four of these cases were severe (<50 × 109/L). No cases were complicated by intracranial hemorrhage, and there was no neonatal mortality. Platelet counts at birth of neonates born to mothers, who had first been diagnosed with ITP during pregnancy were significantly higher than those born to mothers diagnosed with ITP before pregnancy. There were significant correlations between neonatal platelet counts in the first and second siblings at birth (P = 0.015) and at nadir (P = 0.035). Platelet counts of neonates born vaginally were significantly more likely to decline after birth than those delivered by cesarean section (13/16 vs. 10/23, P = 0.024). In conclusion, diagnosis of ITP before pregnancy was significantly associated with neonatal thrombocytopenia, and the platelet count of an older sibling is a strong predictor for that of the next baby. The delivery mode may be an indicator of the timing of platelet count nadir after birth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CBC:

Complete blood count

emCS:

Emergency cesarean section

ITP:

Immune thrombocytopenia

IVIG:

Intravenous immunoglobulin

mPSL:

Methylprednisolone

plCS:

Planned cesarean section

PSL:

Prednisolone

References

  1. Gill KK, Kelton JG. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol. 2000;37:275–89.

    Article  CAS  PubMed  Google Scholar 

  2. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008.

    Article  PubMed  Google Scholar 

  3. Van der Lugt NM, van Kampen A, Walther FJ, Brand A, Lopriore E. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura. Vox Sang. 2013;105:236–43.

    Article  PubMed  Google Scholar 

  4. Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003;102:4306–11.

    Article  CAS  PubMed  Google Scholar 

  5. Veneri D, Franchini M, Raffaelli R, Musola M, Memmo A, Franchi M, et al. Idiopathic thrombocytopenic purpura in pregnancy: Analysis of 43 consecutive cases followed at a single Italian institution. Ann Hematol. 2006;85:552–4.

    Article  PubMed  Google Scholar 

  6. Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA, American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–207.

    Article  CAS  PubMed  Google Scholar 

  7. Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol. 2012;87:15–21.

    Article  PubMed  Google Scholar 

  8. Iwata A, Matsubara K, Hirata T. Repetitive combined therapy of high-dose immunoglobulins and steroids for a neonate with severe passive autoimmune thrombocytopenia. J Jpn Soc Perinat Neonatal Med. 2005;41:85–8 (in Japanese with English abstract).

    Google Scholar 

  9. Christiaens GC, Nieuwenhuis HK, Bussel JB. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol. 1997;90:546–52.

    Article  CAS  PubMed  Google Scholar 

  10. Roberts I, Stanworth S, Murray NA. Thrombocytopenia in the neonate. Blood Rev. 2008;22:173–86.

    Article  PubMed  Google Scholar 

  11. Ajzenberg N, Dreyfus M, Kaplan C, Yvart J, Weill B, Tchernia G. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood. 1998;92:4573–80.

    CAS  PubMed  Google Scholar 

  12. Samuels P, Bussel JB, Braitman LE, Tomaski A, Druzin ML, Mennuti MT, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med. 1990;323:229–35.

    Article  CAS  PubMed  Google Scholar 

  13. Payne SD, Resnik R, Moore TR, Hedriana HL, Kelly TF. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol. 1997;177:149–55.

    Article  CAS  PubMed  Google Scholar 

  14. Kelton JG. Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev. 2002;16:43–6.

    Article  PubMed  Google Scholar 

  15. Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121:38–47.

    Article  CAS  PubMed  Google Scholar 

  16. Fujimura K, Harada Y, Fujimoto T, Kuramoto A, Ikeda Y, Akatsuka J, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 2002;75:426–33.

    Article  PubMed  Google Scholar 

  17. Sharon R, Tatarsky I. Low fetal morbidity in pregnancy associated with acute and chronic idiopathic thrombocytopenic purpura. Am J Hematol. 1994;46:87–90.

    Article  CAS  PubMed  Google Scholar 

  18. Fujita A, Sakai R, Matsuura S, Yamamoto W, Ohshima R, Kuwabara H, et al. A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study. Int J Hematol. 2010;92:463–7.

    Article  PubMed  Google Scholar 

  19. Kunishima S, Kashiwagi H, Otsu M, Takayama N, Eto K, Onodera M, et al. Heterozygous ITGA2B R995 W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia. Blood. 2011;117:5479–84.

    Article  CAS  PubMed  Google Scholar 

  20. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574–96.

    Article  Google Scholar 

  21. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by a research grant from the Japanese Ministry of Health, Labour and Welfare.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koji Kawaguchi.

About this article

Cite this article

Kawaguchi, K., Matsubara, K., Takafuta, T. et al. Factors predictive of neonatal thrombocytopenia in pregnant women with immune thrombocytopenia. Int J Hematol 99, 570–576 (2014). https://doi.org/10.1007/s12185-014-1562-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-014-1562-6

Keywords

Navigation